IMW 2019 | Advances in myeloma genomics and tailored patient therapy

Wee Joo Chng

Wee Joo Chng, PhD, of the Yong Loo Lin School of Medicine, National University of Singapore, Singapore provides a brief update on multiple myeloma genomics, as has been presented at the International Myeloma Workshop (IMW) 2019, in Boston, MA. He touches on the compelling research into how the gut microbiome may drive disease progression, and how this would affect immunotherapy.

Share this video